GIP RECEPTOR AGONIST AND USE THEREOF

The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LI, Wenchen, LI, Honghao, XIE, Haisong, ZHAO, Yingchi, XU, Hongmei
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity at GIP receptors and selectively activate the GIP receptors, and may be used in the manufacture of medicaments associated with type 2 diabetes and weight loss.